July 14, 2026- FedEx Corp. announced the launch of FedEx Life Sciences, a dedicated organization created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments.
As medicine becomes more specialized, global, and time-sensitive, life sciences companies need logistics networks built for precision, visibility, and reliability. From temperature-sensitive therapies and clinical trial materials to medical devices and patient-critical shipments, healthcare supply chains now require specialized support across highly regulated markets.
FedEx Life Sciences brings together the strength of the FedEx global network with a dedicated healthcare team and advanced monitoring capabilities to serve pharmaceutical and healthcare professionals working to deliver care to patients around the world.
As part of the launch, Nick Gennari will exclusively focus on this segment as president of healthcare and life sciences. Gennari joined FedEx in 1992 and has spent much of his more than 30-year tenure driving strategic sales and supply chain solutions for global healthcare, aerospace, and high-tech customers, before assuming leadership of the healthcare vertical in 2024. His appointment to lead this newly specialized organization reflects the FedEx commitment to pairing deep, long-standing sector expertise with its global logistics and technological capabilities. Gennari and his team’s efforts have been instrumental in growing FedEx healthcare revenue to approximately $10 billion globally.